INIS
inhibition
100%
lipids
100%
kinases
80%
membranes
60%
cholesterol
60%
apoptosis
40%
humans
20%
regulations
20%
phosphorylation
20%
signals
20%
cancer
20%
sensitivity
20%
growth factors
20%
inactivation
20%
plasma
20%
extraction
20%
receptors
20%
stimuli
20%
proliferation
20%
oligosaccharides
20%
deactivation
20%
Keyphrases
Lipid Rafts
100%
AKT Pathway
100%
Mammalian Target of Rapamycin (mTOR)
20%
Membrane Cholesterol
20%
Pleckstrin Homology Domain
20%
Precancerous
20%
Forkhead Box O3 (FOXO3)
20%
Plasma Membrane Domains
20%
Pharmacological Targets
20%
Phosphatidylinositol
20%
Akt Kinase
20%
A431
20%
Rich Plasma
20%
PIP3
20%
Cholesterol Extraction
20%
Phosphatidylinositol 4,5-bisphosphate (PIP2)
20%
Filipin III
20%
Epidermal Growth Factor Receptor
20%
Regulatory Site
20%
β-cyclodextrin (β-CD)
20%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Kinase B
50%
Pleckstrin
50%
Methyl Beta Cyclodextrin
50%
Mammalian Target of Rapamycin
50%
Phosphatidylinositol
50%
Phosphatidylinositol 4,5 Bisphosphate
50%
Epidermal Growth Factor Receptor
50%
Phosphatidylinositol 3,4,5 Trisphosphate
50%
Neuroscience
Akt Signaling
100%
Lipid Raft
100%
Phosphatidylinositol (3,4,5)-trisphosphate
20%
Epidermal Growth Factor Receptor
20%
Phosphatidylinositol
20%
Filipin
20%
Phosphatidylinositol 4,5-bisphosphate
20%
Pleckstrin Homology Domain
20%
Mammalian Target of Rapamycin
20%
Methyl Beta Cyclodextrin
20%